drugset / Trial / NCT02693002
Estrogen Diastolic Heart Failure
RandomizedParallel-groupTriple-blindPrevention
Summary
Peri-menopausal women will be randomized to hormone replacement therapy or placebo for 12 weeks to determine if markers of systolic and diastolic function change by echocardiography as well as laboratory markers of heart failure, including b-type natriuretic peptide (BNP).
Timeline
- Start
- 2016-02
- Primary completion
- 2016-11
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Estradiol | Other / unclassified | 1 mg | Oral |
| Comparator | Norethindrone | Unknown | 0.5 mg | Oral |
Indications
No indication recorded.